GE Healthcare Revenues Decline by 4%GE Healthcare Revenues Decline by 4%

The healthcare unit is experiencing pressure from supply chain issues.

Omar Ford

January 25, 2022

1 Min Read
IMG_2022-1-25-130231.jpg
Ceri Breeze / Alamy Stock Photo

GE Healthcare’s 4Q21 revenue took a beating because of inflation and supply chain issues – a common theme in earnings for many companies. The revenue drop for GE Healthcare comes hot on the heels of its parent company Boston-based General Electric announcing it would break up into three different businesses.   

GE Healthcare said it had more than $4.6 billion in sales that’s a 4.1% decline when compared to this time last year. However, GE said the healthcare segment was in position for continued profitable growth. 

The overall picture for GE, the healthcare unit’s parent company is similar. Overall, GE saw a 3% dip in revenue. The company said it expects adjusted profit in the range of $2.80 per share to $3.50 per share in 2022, compared with $1.71 per share in 2021.

A bright spot for GE is its aviation business, which saw a revenue increase.

GE Chairman and CEO H. Lawrence Culp, Jr. said, “2021 was an important year for the GE team, marked by significant strategic, operational, and financial progress. We delivered solid margin, EPS, and free cash flow performance in 2021, exceeding our outlook. Orders for the year were up double digits, supporting faster growth going forward, while supply chain challenges, commercial selectivity, and uncertainty surrounding the U.S. wind production tax credit impacted our top-line."

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like